Letter Sequence Request |
|---|
EPID:L-2021-LLA-0181, Response to the Request for Additional Information Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations (Approved, Closed) |
|
MONTHYEAR1CAN092101, License Amendment Request Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations2021-09-30030 September 2021
License Amendment Request Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations
Project stage: Request
ML21320A2122021-11-17017 November 2021
Supplemental Information Needed for Acceptance of Requested Licensing Action License Amendment Request Concerning Revised Dose Calculations
Project stage: Acceptance Review
1CAN122101, Response to Request for Supplemental Information Concerning Licensing Amendment Request to Revise Technical Specification 3.4.12 and 3.4.132021-12-0202 December 2021
Response to Request for Supplemental Information Concerning Licensing Amendment Request to Revise Technical Specification 3.4.12 and 3.4.13
Project stage: Supplement
ML21341B2262021-12-13013 December 2021
Acceptance of Requested Licensing Action License Amendment Request to Revise Technical Specifications 3.4.12 and 3.4.13 Based on Revised Dose Calculations
Project stage: Acceptance Review
ML22019A1342022-01-21021 January 2022
Audit Plan to Support Review of License Amendment Request for Technical Specification Changes Due to Revised Dose Calculations
Project stage: Other
ML22108A1642022-04-18018 April 2022
NRR E-mail Capture - ANO-1: Final RAI License Amendment Request Concerning TS Changes Due to Revised Dose Calculations (L-2021-LLA-0181)
Project stage: RAI
1CAN062201, Response to the Request for Additional Information Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations2022-06-0202 June 2022
Response to the Request for Additional Information Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations
Project stage: Request
ML22174A3342022-07-12012 July 2022
Regulatory Audit Summary Concerning License Amendment Request for Technical Specification Changes Due to Revised Dose Calculations
Project stage: Other
ML22181A0582022-07-15015 July 2022
Request for Withholding Information from Public Disclosure
Project stage: Withholding Request Acceptance
1CAN102201, Supplement to Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations2022-10-13013 October 2022
Supplement to Proposed Technical Specifications 3.4.12 and 3.4.13 Revised Dose Calculations
Project stage: Request
ML22291A2402022-10-28028 October 2022
Notice of Consideration of Issuance of Amendment to Renewed Facility Operating License, Proposed Nshcd, and Opportunity for a Hearing and Order Imposing Procedures for Document Access to SUNSI (EPID L-2021-LLA-0181) (FRN)
Project stage: Other
ML22291A2552022-10-28028 October 2022
Notice of Consideration of Issuance of Amendment to Renewed Facility Operating License, Proposed Nshcd, and Opportunity for a Hearing and Order Imposing Procedures for Document Access to SUNSI
Project stage: Request
ML22291A2392022-10-28028 October 2022
Notice of Consideration of Issuance of Amendment to Renewed Facility Operating License, Proposed Nshcd, and Opportunity for a Hearing and Order Imposing Procedures for Document Access to SUNSI (EPID L-2021-LLA-0181) Letter
Project stage: Other
ML22305A5632022-11-28028 November 2022
Request for Withholding Information from Public Disclosure
Project stage: Withholding Request Acceptance
ML22263A1912022-12-0909 December 2022
Issuance of Amendment No. 278 Revision to Technical Specifications 3.4.12 and 3.4.13 Based on Revised Dose Calculations (EPID L-2021-LLA-0181) - Non-Proprietary
Project stage: Approval
2022-10-28
[Table View] |
